Impact Factor 3.552

The 2nd most cited open-access journal in Clinical Neurology

Original Research ARTICLE

Front. Neurol., 02 June 2017 | https://doi.org/10.3389/fneur.2017.00242

Adverse Childhood Experiences Are Linked to Age of Onset and Reading Recognition in Multiple Sclerosis

imageMichael T. Shaw1, imageNatalie O. Pawlak1, imageAriana Frontario2, imageKathleen Sherman1, imageLauren B. Krupp1 and imageLeigh E. Charvet1*
  • 1Department of Neurology, NYU Langone Medical Center, New York, NY, United States
  • 2Lake Erie College of Osteopathic Medicine, Erie, PA, United States

Background: Adverse childhood experiences (ACEs) exert a psychological and physiological toll that increases risk of chronic conditions, poorer social functioning, and cognitive impairment in adulthood.

Objective: To investigate the relationship between childhood adversity and clinical disease features in multiple sclerosis (MS).

Methods: Sixty-seven participants with MS completed the ACE assessment and neuropsychological assessments as part of a larger clinical trial of cognitive remediation.

Results: Adverse childhood experience scores, a measure of exposure to adverse events in childhood, significantly predicted age of MS onset (r = –0.30, p = 0.04). ACEs were also linked to reading recognition (a proxy for premorbid IQ) (r = –0.25, p = 0.04). ACE scores were not related to age, current disability, or current level of cognitive impairment measured by the Symbol Digit Modalities Test (SDMT).

Conclusion: Childhood adversity may increase the likelihood of earlier age of onset and poorer estimated premorbid IQ in MS.

Introduction

Childhood adversity and the associated chronic psychological and physiological stress have been shown to lead to poorer health in adults, including susceptibility to proinflammatory states and chronic conditions (13). Adults with a history of traumatic experiences in childhood have been found to have smaller prefrontal cortex (4, 5) and hippocampal volume (6) and greater activation of the hypothalamic–pituitary–adrenal (HPA) axis (7) (which mediates the body’s physiological response to psychosocial and environmental stress) compared to non-maltreated individuals. Moreover, previous studies have linked history of childhood adversity to biomarkers of inflammation, such as C-reactive protein, that increase susceptibility to autoimmune diseases in adulthood (1, 2, 810).

Multiple sclerosis (MS) is a complex autoimmune disorder that destroys the myelin sheath and neurons in the brain and spinal cord, resulting in lesions, plaques, and scars at the inflamed sites. Recent studies have made progress in identifying the genetic and environmental components of disease vulnerability (e.g., exposure to tobacco smoke, Epstein–Barr virus (EBV) infection, and inadequate vitamin D levels), but the exact etiology of MS is still unknown. In patients with MS, hyperactivity of the HPA axis was found to be correlated with MRI activity, clinical disability, and cognitive impairment (1113). Exposure to major negative life events was found to be predictive of gadolinium-enhancing and T2 lesions on MRI scans in patients with MS (14). Studies looking at psychosocial factors influencing disease onset found that cohorts of participants with MS had a higher prevalence of negative life events, self-defined family problems, and poorer utilization of social support resources compared to healthy controls (15).

Adverse events occurring as early as childhood have been linked to MS clinical disease features. For example, emotional and physical abuse and neglect in childhood have been associated with increased rates of relapses in a cohort of adult MS patients (16). However, the exact role of early-life adversity in MS remains unclear. Determining the physiologic effects of childhood stress in the context of psychophysiological vulnerability to MS onset and progression is important for implementing more effective and early approaches to improve resilience.

The adverse childhood experience (ACE) inventory is a validated, reliable, and easily implemented assessment of childhood adversity through a study including 17,337 adult participants conducted by the CDC and the Kaiser Foundation Health Plan in San Diego, California (17). In this study, ACE scores were found to be highly predictive of risk for a number of chronic conditions and emotional dysfunction in adulthood. An ACE score of 4 or more exposures denoted a severely adverse childhood that exponentially increases risk of chronic conditions, suicide attempts, psychiatric disorders, poor self-rated health, physical inactivity, obesity, ≥50 sexual intercourse partners, sexually transmitted diseases, and harmful lifestyle choices such as smoking compared to those who had not experienced any adverse childhood events (3). In this study, we tested the relationship between childhood adversity and MS clinical disease features using the ACE survey.

Materials and Methods

Study Selection

The study participants were individuals with MS recruited from a larger sample of n = 135 participants with MS who had completed a 12-week clinical trial of a cognitive remediation program at Stony Brook Medicine (18). Following study completion, participants were contacted by phone with the opportunity to participate in an online survey study from home.

Written, informed consent was obtained from all participants before the initiation of any specific procedures. Study procedures were approved from Stony Brook University’s Human Subjects Committee Institutional Review Board and the CORIHS B, board reference number: 2013-2110-R3. Participants were actively recruited for the cognitive remediation trial between July 2014 and June 2015.

The following were included as eligibility criteria for the larger trial: age between 18 and 70 years; definite diagnosis of MS (of any subtype) by a treating neurologist; lack of other primary CNS or medical disorder that would influence ability to participate; lack of other uncontrolled serious medical conditions (e.g., cancer); no history of alcohol or other substance abuse disorder; native proficiency of the English language (defined as learning English before the age of 12 years). As part of the larger cognitive remediation trial, participants were also required to have at least suspected cognitive impairment, as measured by scoring at least 1 SD or below on the Symbol Digit Modalities Test (SDMT) (19) and within the average range on Wide Range Achievement Test-third edition (WRAT-3) (20).

Cognitive Measures

For the current study, the SDMT screening and WRAT-3 reading subtest scores from the clinical trial were used to represent current cognitive information processing and oral reading recognition, respectively. The SDMT is a brief information processing measure that is widely accepted measure of MS-related cognitive involvement (21). Reading recognition as measured by the WRAT-3 (22) is a commonly accepted proxy of estimated premorbid IQ (2325). These measures were administered from 4 to 18 months prior to the completion of the survey; however, both measures have well-demonstrated reliability over time and would not be expected to change significantly over this time period (26).

Childhood Adversity Questionnaire

The ACE questionnaire is a 10-item measure of childhood adversity including household dysfunction, neglect, and emotional, physical, and sexual abuse. Exposure to each adverse event counts as a point toward one’s ACE score, with higher ACE scores indicating greater exposure to traumatic and stressful events in childhood (3). Of note, an ACE score of 4 or more exposures represents a severely adverse childhood that exponentially increases risk of chronic conditions, suicidality, psychiatric disorders, obesity, and other health outcomes in adulthood compared to those without ACEs. In this study, we correlated ACE scores with clinical disease features in our cohort of MS patients using IBM SPSS Statistics 23. Baseline characteristics for the ACE questionnaire are shown in Table 1.

TABLE 1
www.frontiersin.org

Table 1. Childhood adversity descriptors—primary measures.

Results

Of the n = 135 cognitive remediation trial participants, n = 79 responded with interest in this study and n = 67 fully completed the online ACE survey. Demographic and clinical features for the n = 67 participants are shown in Table 2.

TABLE 2
www.frontiersin.org

Table 2. Demographic and baseline clinical characteristics.a

The mean ACE score of our cohort was 1.93 ± 2.45, denoting that on average, participants experienced two ACEs in their lifetime. Comparing the ACE distribution of our study cohort to the prevalence found in the CDC-Kaiser Permanente ACE study sample, our cohort of MS patients reported a higher number of ACEs (Figure 1), with more individuals in our MS sample meeting criteria for a severely adverse childhood that exponentially increases health risk in adulthood compared to those in the CDC-Kaiser Permanente cohort.

FIGURE 1
www.frontiersin.org

Figure 1. Adverse childhood experience prevalence in CDC-Kaiser Permanente study sample and multiple sclerosis (MS) study cohort.

Of the 67 participants with ACE data, n = 46 had provided date of disease onset. ACE scores were significantly and inversely correlated with age of MS onset (r = −0.30, p = 0.04), indicating that a greater exposure to ACEs is predictive of earlier age of disease onset (Figure 2).

FIGURE 2
www.frontiersin.org

Figure 2. Adverse childhood experience (ACE) scores are predictive of age of multiple sclerosis onset.

In addition, all 67 participants who completed the ACE questionnaire also performed neuropsychological testing for cognitive remediation measures. Performance on the WRAT-3 reading recognition was significantly linked to participants’ ACE scores (r = −0.25, p = 0.04; Figure 3), indicating that childhood adversity was also predictive of premorbid IQ.

FIGURE 3
www.frontiersin.org

Figure 3. Estimated premorbid IQ* is associated with adverse childhood experience (ACE) scores. *Obtained from Wide Range Achievement Test-third edition (WRAT-3) Reading Subset.

Discussion

In this survey study, adults with MS reported ACEs that were consistent with those found in the larger epidemiologic study conducted at Kaiser Permanente, with the exception of an overrepresentation of participants meeting criteria for a severely adverse childhood (i.e., 4 or more ACEs). Further, when assessing ACE scores, those participants reporting greater childhood adversity had significantly earlier age of disease onset. ACE scores were also predictive of estimated premorbid IQ, but were not predictive of SDMT scores, which serve as a measure of current MS-related cognitive involvement.

The study results suggest that physiological vulnerability to MS disease is linked to childhood exposure to adverse experiences. There are several considerations in linking childhood adversity to MS onset. These findings are consistent with previous literature suggesting that childhood adversity induces physiological dysregulation that increases the risk of developing chronic conditions as an adult (13, 27). Uncovering the link between childhood adversities and disease onset helps to build our understanding of the cumulative effects of stress on long-term health and MS susceptibility.

This study has several major limitations. First, there are additional potentially mediating factors to the findings that were not available such as socioeconomic status and nutrition in childhood that would likely correspond to higher ACE scores or mitigating factors such as social support that could reduce the impact of childhood adversity (28). In addition, there are numerous known and suspected factors that contribute to the onset of MS [e.g., geographic location (29), vitamin D levels (30), and additional genetic and environmental factors (31)] that would add to a richer interpretation of the current findings.

One of the possible mechanisms through which childhood adversity influences physiological dysregulation is changes in biological processes known as allostatic mechanisms. Through allostatic mechanisms, the body mobilizes adaptive processes in response to environmental and psychosocial stressors (32). In the short term, these processes are protective. However, chronic and repeated exposure to extreme stress can lead to a physiological “wear and tear” of the body, either through multiple cycles of allostasis or through the inefficient turning on and shutting off of allostatic responses (32). The overtaxing of adaptive processes mediated by the endocrine, immune, and nervous systems in allostasis is defined as allostatic load, which leads to harmful physiological dysregulation. For example, allostatic load involves glucocorticoid hyperactivity induced by prolonged and repeated exposure to stress that has been associated with reduced memory performance, most likely due to decreased neurogenesis and neuroplasticity in glucocorticoid-sensitive brain areas such as the hippocampus (3335). Future studies in MS should investigate biometric indices to mark the presence of stress-induced physiological overtaxing across the lifespan and to better understand the role of physiologic stress relative to MS vulnerability and cognitive involvement. Various validated measures of allostatic load exist that could be implemented in clinical visits to assess stress-induced wear and tear of allostatic mechanisms across the lifespan of MS patients. These measures of allostatic load could be compared to participants’ reported ACE scores to hone in on how childhood adversity influences physiological “wear and tear” that promotes biological vulnerability to MS and early-age onset.

A few factors are important to consider in the generalizability of our findings. First, through surveying those participants in our clinical trial of cognitive remediation, we included a sample with probable cognitive impairment. While this is a common feature of MS, with impairment on the SDMT is estimated at up to 70% of MS in general (36), this sample did not represent those patients living without cognitive involvement of the disease. Also, by surveying trial participants up to 18 months after study completion, the timing of the cognitive measures was not concurrent with the survey data in some cases. However, both of the cognitive measures are expected to be generally stable over time and would not be expected to significantly influence our findings (20, 26). Our study cohort had a gender distribution that was predominantly female (77.60%), unlike the sample in the original ACE study conducted by the CDC and Kaiser Permanente, which had a relatively even gender distribution (54% female). Research has shown that women are more likely than men to experience sexual abuse and neglect in childhood (37, 38). There are also proven sex differences in severity of reaction to traumatic experiences, with women being more prone to develop PTSD and hence, stress-induced physiologic dysregulation (38). Both of these factors could contribute to the greater prevalence of self-reported severely traumatic childhoods (defined as having an ACE score equal to or greater than 4) in our MS study sample compared to the ACE study sample. Nevertheless, these gender differences have also been observed in MS and other autoimmune disorders, with women being two to three times more likely to develop MS compared to male counterparts (39). This study’s participants exhibited MS-related cognitive impairment and provided an additional limitation to obtaining self-reported measures on childhood experiences for the full range of the MS population.

Conclusion

This is the first study, to our knowledge, to examine the influence of ACE scores in MS clinical features. Findings support a role of childhood adversity in MS disease onset. Ultimately, therapeutic interventions for stress management may be useful, as well as interventions in childhood that focus on the development of strategies of resilience. Childhood exposure to psychosocial stressors, early trauma-induced reactions, and resilient coping strategies for stress management should be considered along with other predictive factors to promote healthier aging and to prevent cognitive decline across the lifespan in MS patients.

Ethics Statement

The study protocol was approved by and was carried out in accordance with the recommendations of the Stony Brook University’s Human Subjects Committee Institutional Review Board (IRB) and the CORIHS B, board reference number: 2013-2110-R3, with written or verbal informed consent obtained from all subjects. All subjects gave written or verbal informed consent in accordance with the Declaration of Helsinki.

Author Contributions

All mentioned authors have significantly contributed to the manuscript as outlined by the Frontiers Multiple Sclerosis and Neuroimmunology authorship guidelines. All authors participated in drafting and revising the work and in the final approval process, and all agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated. Corresponding author LC and author KS made substantial contributions to the conception and design of the work; authors MS, NP, and AF significantly contributed to the acquisition, analysis, and interpretation of collected data.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Funding

The study was funded by the National Multiple Sclerosis Society (grant number: 4808A81).

References

1. Danese A, McEwen BS. Adverse childhood experiences, allostasis, allostatic load, and age-related disease. Physiol Behav (2012) 106(1):29–39. doi: 10.1016/j.physbeh.2011.08.019

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Dube SR, Fairweather D, Pearson WS, Felitti VJ, Anda RF, Croft JB. Cumulative childhood stress and autoimmune diseases in adults. Psychosom Med (2009) 71(2):243–50. doi:10.1097/PSY.0b013e3181907888

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med (1998) 14(4):245–58. doi:10.1016/S0749-3797(98)00017-8

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Hanson JL, Chung MK, Avants BB, Shirtcliff EA, Gee JC, Davidson RJ, et al. Early stress is associated with alterations in the orbitofrontal cortex: a tensor-based morphometry investigation of brain structure and behavioral risk. J Neurosci (2010) 30(22):7466–72. doi:10.1523/JNEUROSCI.0859-10.2010

PubMed Abstract | CrossRef Full Text | Google Scholar

5. De Bellis MD, Keshavan MS, Shifflett H, Iyengar S, Beers SR, Hall J, et al. Brain structures in pediatric maltreatment-related posttraumatic stress disorder: a sociodemographically matched study. Biol Psychiatry (2002) 52(11):1066–78. doi:10.1016/S0006-3223(02)01459-2

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Rao U, Chen LA, Bidesi AS, Shad MU, Thomas MA, Hammen CL. Hippocampal changes associated with early-life adversity and vulnerability to depression. Biol Psychiatry (2010) 67(4):357–64. doi:10.1016/j.biopsych.2009.10.017

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Cicchetti D, Rogosch FA. The impact of child maltreatment and psychopathology on neuroendocrine functioning. Dev Psychopathol (2001) 13(4):783–804.

PubMed Abstract | Google Scholar

8. Baumeister D, Akhtar R, Ciufolini S, Pariante CM, Mondelli V. Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-alpha. Mol Psychiatry (2016) 21(5):642–9. doi:10.1038/mp.2015.67

CrossRef Full Text | Google Scholar

9. Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev (2010) 35(1):2–16. doi:10.1016/j.neubiorev.2009.10.002

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Slopen N, Kubzansky LD, McLaughlin KA, Koenen KC. Childhood adversity and inflammatory processes in youth: a prospective study. Psychoneuroendocrinology (2013) 38(2):188–200. doi:10.1016/j.psyneuen.2012.05.013

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Then Bergh F, Kümpfel T, Trenkwalder C, Rupprecht R, Holsboer F. Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology (1999) 53(4):772. doi:10.1212/WNL.53.4.772

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Heesen C, Gold SM, Raji A, Wiedemann K, Schulz KH. Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis. Psychoneuroendocrinology (2002) 27(4):505–17. doi:10.1016/S0306-4530(01)00071-3

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Schumann EM, Kumpfel T, Then Bergh F, Trenkwalder C, Holsboer F, Auer DP. Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume. Ann Neurol (2002) 51(6):763–7. doi:10.1002/ana.10187

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Burns MN, Nawacki E, Kwasny MJ, Pelletier D, Mohr DC. Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis? Psychol Med (2014) 44(2):349–59. doi:10.1017/S0033291713000755

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Liu XJ, Ye HX, Li WP, Dai R, Chen D, Jin M. Relationship between psychosocial factors and onset of multiple sclerosis. Eur Neurol (2009) 62(3):130–6. doi:10.1159/000226428

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Spitzer C, Bouchain M, Winkler LY, Wingenfeld K, Gold SM, Grabe HJ, et al. Childhood trauma in multiple sclerosis: a case-control study. Psychosom Med (2012) 74(3):312–8. doi:10.1097/PSY.0b013e31824c2013

PubMed Abstract | CrossRef Full Text | Google Scholar

17. CDC. About the CDC-Kaiser ACE Study. Atlanta, GA: Centers for Disease Control and Prevention (2016). Available from: http://www.cdc.gov/violenceprevention/acestudy/about.html

Google Scholar

18. Charvet LE, Yang J, Shaw MT, Sherman K, Haider L, Xu J, et al. Cognitive function in multiple sclerosis improves with telerehabilitation: results from a randomized controlled trial. PLoS One (2017) 12(5):e0177177. doi:10.1371/journal.pone.0177177

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Smith A. The Symbol Digit Modalities Test (SDMT): Manual. Los Angeles, CA: Western Psychological Services (1982).

Google Scholar

20. Wilkinson GS. WRAT3: Wide Range Achievement Test Administration Manual. Wilmington, DE: Wide Range, Inc. (1993).

Google Scholar

21. Van Schependom J, D’hooghe MB, Cleynhens K, D’hooge M, Haelewyck MC, De Keyser J, et al. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis. Eur J Neurol (2014) 21(9):1219–25, e71–2. doi:10.1111/ene.12463

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Spreen O, Esther S. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford University Press (1998). p. 164–6.

Google Scholar

23. Smith GE, Bohac DL, Ivnik RJ, Malec JF. Using word recognition tests to estimate premorbid IQ in early dementia: longitudinal data. J Int Neuropsychol Soc (1997) 3(6):528–33.

PubMed Abstract | Google Scholar

24. Gladsjo JA, Heaton RK, Palmer BW, Taylor MJ, Jeste DV. Use of oral reading to estimate premorbid intellectual and neuropsychological functioning. J Int Neuropsychol Soc (1999) 5(3):247–54. doi:10.1017/S1355617799533079

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Bright P, Jaldow E, Kopelman MD. The National Adult Reading Test as a measure of premorbid intelligence: a comparison with estimates derived from demographic variables. J Int Neuropsychol Soc (2002) 8(6):847–54. doi:10.1017/S1355617702860131

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Morrow SA, O’Connor PW, Polman CH, Goodman AD, Kappos L, Lublin FD, et al. Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks. Mult Scler (2010) 16(11):1385–92. doi:10.1177/1352458510378021

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Bellis MA, Lowey H, Leckenby N, Hughes K, Harrison D. Adverse childhood experiences: retrospective study to determine their impact on adult health behaviours and health outcomes in a UK population. J Public Health (2014) 36(1):81–91. doi:10.1093/pubmed/fdt038

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Ginsburg KR. A Parent’s Guide to Building Resilience in Children and Teens: Giving Your Child Roots and Wings. American Academy of Pediatrics (2006). Available from: http://www.healthycommunitiesme.org/assets/files/Healthy%20Start/ARCPamphlet(1).pdf

Google Scholar

29. Chunrong T, Simpson S Jr, van der Mei I, Blizzard L, Havrdova E, Horakova D, et al. Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis. J Neurol Neurosurg Psychiatry (2016) 87(12):1343–9. doi:10.1136/jnnp-2016-314013

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Munger KL, Zhang SM, O’Reilly E, Hernan MA, Olek MJ, Willett WC, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology (2004) 62(1):60–5. doi:10.1212/01.WNL.0000101723.79681.38

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Chitnis T, Krupp L, Yeh A, Rubin J, Kuntz N, Strober JB, et al. Pediatric multiple sclerosis. Neurol Clin (2011) 29(2):481–505. doi:10.1016/j.ncl.2011.01.004

PubMed Abstract | CrossRef Full Text | Google Scholar

32. McEwen BS. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology (2000) 22(2):108–24. doi:10.1016/S0893-133X(99)00129-3

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Lupien SJ, McEwen BS, Gunnar MR, Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci (2009) 10(6):434–45. doi:10.1038/nrn2639

PubMed Abstract | CrossRef Full Text | Google Scholar

34. McEwen BS, Sapolsky RM. Stress and cognitive function. Curr Opin Neurobiol (1995) 5(2):205–16. doi:10.1016/0959-4388(95)80028-X

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Seeman TE, McEwen BS, Singer BH, Albert MS, Rowe JW. Increase in urinary cortisol excretion and memory declines: MacArthur studies of successful aging. J Clin Endocrinol Metab (1997) 82(8):2458–65. doi:10.1210/jcem.82.8.4173

CrossRef Full Text | Google Scholar

36. Benedict RH, Duquin JA, Jurgensen S, Rudick RA, Feitcher J, Munschauer FE, et al. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Mult Scler (2008) 14(7):940–6. doi:10.1177/1352458508090923

PubMed Abstract | CrossRef Full Text | Google Scholar

37. PTSD NCf. Women, Trauma, and PTSD. U.S. Department of Veteran Affairs (2016). Available from: http://www.ptsd.va.gov/public/PTSD-overview/women/women-trauma-and-ptsd.asp

Google Scholar

38. Tolin DF, Foa EB. Sex differences in trauma and posttraumatic stress disorder: a quantitative review of 25 years of research. Psychol Bull (2006) 132(6):959–92. doi:10.1037/0033-2909.132.6.959

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Whitacre CC, Reingold SC, O’Looney PA. A gender gap in autoimmunity. Science (1999) 283(5406):1277–8. doi:10.1126/science.283.5406.1277

CrossRef Full Text | Google Scholar

Keywords: adverse childhood experiences, multiple sclerosis, age of onset, premorbid IQ, childhood abuse

Citation: Shaw MT, Pawlak NO, Frontario A, Sherman K, Krupp LB and Charvet LE (2017) Adverse Childhood Experiences Are Linked to Age of Onset and Reading Recognition in Multiple Sclerosis. Front. Neurol. 8:242. doi: 10.3389/fneur.2017.00242

Received: 15 February 2017; Accepted: 17 May 2017;
Published: 02 June 2017

Edited by:

Robert Weissert, University of Regensburg, Germany

Reviewed by:

Lürding Ralf, University of Regensburg, Germany
Frederick Robert Carrick, Bedfordshire Centre for Mental Health Research in Association with University of Cambridge, United Kingdom

Copyright: © 2017 Shaw, Pawlak, Frontario, Sherman, Krupp and Charvet. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Leigh E. Charvet, leigh.charvet@nyumc.org